Rucha Patil: Advancing Haemostasis Through Science, Collaboration and Innovation at NHU 2026
Rucha Patil, Scientist at Department of Haemostasis and Thrombosis, ICMR- National Institute of Immunohaematology, shared a post on LinkedIn:
“NHU 2026 | Advancing Haemostasis Through Science, Collaboration and Innovation
The 15th National Haemostasis Update (NHU) 2026, held on 1–2 August 2026 in Bengaluru, Organised by the Indian Association for Haemophilia and Allied Disorders (IAHAD) brought together clinicians, nurses, physiotherapists, researchers, and allied healthcare professionals from across India with a shared vision of advancing care for people with haemophilia and other bleeding disorders.
The conference concluded on an exceptionally proud note, with three outstanding laboratory research studies from our team being awarded the Best Poster Awards:
- A Novel Emicizumab-Compatible Lateral Flow Immunoassay for Rapid Detection of Factor VIII Inhibitors
(Rucha Patil, Sharda Shanbhag, Sweta Kaskar, Moni Singh) - Immunogenetic Basis of Factor VIII Inhibitor Development in Severe Haemophilia A Patients: Integrated Analysis of Immune Cell Profiling, Cytokine Signatures, Immune Gene Polymorphisms & Whole Exome Sequencing (sharda shanbhag, Karishma Vyas, Bipin Kulkarni, Rucha Patil)
- Prenatal Insight into a Rare Dual-Lineage Compound Heterozygous Female Foetus Affected by Haemophilia A(Karishma Vyas, Nikesh Kawankar, Babita Phartyal, Rucha Patil, Bipin Kulkarni, Sharda Shanbhag)
Adding another moment of pride, the Best Oral Presentation Award was for:
Real-World Clinical Experience with Very Low-Dose Emicizumab Prophylaxis in Hemophilia A: ‘A Single-Centre Study from a Tertiary Care Institute’ a KEM-ICMR study (Kalpita Pai, Rucha Patil, Kirti Patil, Jai Juverkar, Sayali Rasal)
These recognitions reflect the dedication, teamwork, and commitment of our group towards advancing innovative diagnostics, precision medicine, and improved therapeutic strategies in haemophilia care.”
Stay updated with Hemostasis Today.
-
Sep 21, 2026, 15:56Anita Zaidi: Why Only 2% of Health Research and Development Goes to Women’s Conditions
-
Sep 21, 2026, 15:49Omid Khalafi: Gating Strategy and How Do We Decide Which Cells to Analyze
-
Sep 21, 2026, 15:44Levacetylleucine: A New Therapeutic Approach to Ataxia Telangiectasia
-
Sep 21, 2026, 15:40Andreas Tridimas: The Diagnostic Traps of Lipaemic Blood – Why a Normal Amylase Can Mislead You
-
Sep 21, 2026, 15:33Arsene Mekinian: Exploring Cardiac Involvement in Behçet’s Disease
-
Sep 21, 2026, 15:23Anis Mahjoubi: MRI Findings of Krukenberg Tumors
-
Sep 21, 2026, 15:08Fikreab Tesfaye Tefera: 10 Practical Take-Home Points for Diagnosing Iron Deficiency Anemia
-
Sep 21, 2026, 14:10Aswin K Mohan: Lessons from TRANSCON 2026 – Building Resilient Blood Supply Systems Before Crisis Hits
-
Sep 21, 2026, 14:00Vincent Lu: Beyond PT and aPTT – How Hemostasis Evolves Across a Lifetime